Sonder receives Nasdaq MVPHS notice with 180-day cure window
Rhea-AI Filing Summary
Sonder Holdings Inc. reported a Nasdaq compliance deficiency. On October 21, 2025, Nasdaq notified the company that it no longer meets the Market Value of Publicly Held Shares requirement of $15,000,000 under Listing Rule 5450(b)(3)(C). Sonder has 180 calendar days, until April 20, 2026, to regain compliance by maintaining a MVPHS of $15,000,000 for at least ten consecutive business days.
The notice has no immediate effect on the listing or trading of Sonder’s common stock (SOND) or publicly traded warrants (SONDW) on the Nasdaq Global Select Market.
Positive
- None.
Negative
- Nasdaq MVPHS deficiency notice; must reach $15,000,000 for 10 consecutive business days by April 20, 2026
Insights
Nasdaq MVPHS deficiency adds listing risk but no immediate impact.
Sonder was notified on October 21, 2025 that its Market Value of Publicly Held Shares fell below the $15,000,000 threshold required by Nasdaq Listing Rule 5450(b)(3)(C). To regain compliance, it must sustain a MVPHS at or above $15,000,000 for 10 consecutive business days within the 180-day window.
The notice does not affect trading now, but prolonged non-compliance can lead to delisting proceedings, which may affect liquidity and index eligibility. Actual outcomes depend on market valuation over time and any company actions permitted under exchange rules.
The key milestone is the cure deadline on April 20, 2026; subsequent disclosures may indicate progress toward maintaining the required MVPHS streak.
8-K Event Classification
FAQ
What did Sonder (SOND) announce in its latest 8-K?
What is the compliance deadline for SOND?
What must Sonder achieve to regain Nasdaq compliance?
Does the Nasdaq notice affect SOND or SONDW trading now?
Which Nasdaq rule is cited for SOND’s deficiency?
Which securities are listed for Sonder?